Wilson Sonsini Goodrich & Rosati represented Ochre Bio in the transaction.Ochre Bio, a pioneer in chronic liver disease medicine development, announced the start of a multi-year…
Ochre Bio’s $37.5 Million License Agreement with GSK


Wilson Sonsini Goodrich & Rosati represented Ochre Bio in the transaction.Ochre Bio, a pioneer in chronic liver disease medicine development, announced the start of a multi-year…
…